Leprosy is, still, a major public health problem in India affecting many people every year from all walks of life irrespective of age, sex, religion and social status, though more common among the poor and majority of patients attending our out patient de partment (OPD) are from the poorer section. India is having the maximum numbers of leprosy cases worldwide and presently accounts for 67% and 73% of total prevalence and newly detected cases respec tively'.
History. It is believed that leprosy has its ori gin from ancient India and mention of the disease as "Kustha roga" has been found in "Sushrata Sanhita" , a book on Ayurved, written about 600 years B. C. Table) . ing surveillance period as I had seen, needs further studies to help the clinician. So, is the case for re sidual skin lesions that sometimes persist even after therapy and these quite often pose difficulty in ac ceptance of the patients in the society and compel victims to move from one physician to another in search of cure. Last, but not the least, cessation of therapy (MDT) after one year in some MB cases, especially with high BI (4+ and higher) when ATP activities are remaining high 9) may invite a serious problem in future in the form of a relapse /secondary MDR leprosy as therapy is inadequate in my views in these cases.
